Table 2.
ACRS only | ACRS+9p21 allele |
ACRS+ CIMT+plaque (*) |
ACRS+CIMT+plaque + 9p21allele (*) |
|
---|---|---|---|---|
% reclassified (#) | 8.9 (n=828) | 24.7% (n=2305) | 25.9% (n=2416) | |
G-B goodness of fit test (p value) | 15.75 (p=0.07) | 17.6 (p=0.04) | 14.48 (p=0.11) | 15.27 (p=0.08) |
NRI (%) (#) | −0.5 | 8.3 | 9.8 | |
Clinical NRI (%) (#) | 4.1 | 25.01 | 28.6 | |
IDI (#) | 0.002 | 0.013 | 0.016 |
Comparison of various models to the ARS only model
Comparison of ARS+CIMT+plaque+9p21 allele to ARS+CIMT+plaque: % reclassified 8.6% (n=803), NRI 1.5%, clinical NRI 6.2%, IDI 0.002,
G-B: Grønnesby Borgan test of model calibration; NRI: Net reclassification index; clinical NRI: NRI in the intermediate (5–20% risk groups); IDI: Integrated discrimination index